Narcotic withdrawal symptoms in heroin users treated with propranolol.
D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D005260:Female; D003932:Heroin; D006801:Humans; D008691:Methadone / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D010919:Placebos; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000188:drug therapy*; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D010919:Placebos; D003932:Heroin; D011433:Propranolol; D008691:Methadone